September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Evaluation of AAV-based optogene transfer for the treatment of canine models of inherited retinal dystrophies
Author Affiliations & Notes
  • Baptiste Ameline
    UMR1089, INSERM, Nantes, France
    Atlantic Gene Therapies, Nantes, France
  • Kizito Tshitoko Tshilenge
    UMR1089, INSERM, Nantes, France
    Atlantic Gene Therapies, Nantes, France
  • Lyse Libeau
    Service d'ophtalmologie, CHU Hôtel Dieu, Nantes, France
    UMR1089, INSERM, Nantes, France
  • Alexandra Mendes-Madeira
    UMR1089, INSERM, Nantes, France
    Atlantic Gene Therapies, Nantes, France
  • Nathalie Provost
    UMR1089, INSERM, Nantes, France
    Atlantic Gene Therapies, Nantes, France
  • Michel Weber
    Service d'ophtalmologie, CHU Hôtel Dieu, Nantes, France
  • Jack-Yves Deschamps
    Ecole vétérinaire, Oniris, Nantes, France
  • Véronique Blouin
    UMR1089, INSERM, Nantes, France
    Atlantic Gene Therapies, Nantes, France
  • Virginie Pichard
    UMR1089, INSERM, Nantes, France
    Atlantic Gene Therapies, Nantes, France
  • Philippe Moullier
    UMR1089, INSERM, Nantes, France
    Atlantic Gene Therapies, Nantes, France
  • Fabienne Rolling
    UMR1089, INSERM, Nantes, France
    Atlantic Gene Therapies, Nantes, France
  • Footnotes
    Commercial Relationships   Baptiste Ameline, None; Kizito Tshitoko Tshilenge, None; Lyse Libeau, None; Alexandra Mendes-Madeira, None; Nathalie Provost, None; Michel Weber, None; Jack-Yves Deschamps, None; Véronique Blouin, None; Virginie Pichard, None; Philippe Moullier, None; Fabienne Rolling, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 118. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Baptiste Ameline, Kizito Tshitoko Tshilenge, Lyse Libeau, Alexandra Mendes-Madeira, Nathalie Provost, Michel Weber, Jack-Yves Deschamps, Véronique Blouin, Virginie Pichard, Philippe Moullier, Fabienne Rolling; Evaluation of AAV-based optogene transfer for the treatment of canine models of inherited retinal dystrophies. Invest. Ophthalmol. Vis. Sci. 2016;57(12):118.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Recombinant Adeno-Associated Virus (AAV)-mediated optogene (coding for light-sensitive proteins) transfer into retinal ganglion cells has emerged as a promising strategy to restore photosensitivity in the context of inherited retinal dystrophies (IRD). Optogene transfer in rodent models of IRD demonstrated restoration of visual functions. Assessment of Opn4 or ChR2 optogene transfer in large animal models of IRD is a key step prior evaluation in clinical trials. In this study, we have tested optogenes expression and functionality in vitro. We have also evaluated the restoration of retinal functions after optogene transfer in the retinal ganglion cells of blind Rpe65-deficient dogs.

Methods : We produced plasmid vectors containing either the ChR2 or the human Opn4 sequence under the control of the CMV or the hSyn promoter. Optogenes expression and functionality were validated in vitro by immunocytochemistry and calcium sensor analysis. Moreover, we generated rAAV2/2 vectors carrying the ChR2 or hOpn4 cDNA under the control of the hSyn promoter. We performed an intravitreal injection of vectors in Rpe65-/- dogs with advanced progression of the disease. Immunostaining of ChR2 injected retinas were performed to confirm the transduction of the canine retinal ganglion cells. We assessed the restoration of the retinal function by electroretinogram (ERG) based on standard and adapted procedures for optogene-based retinal ganglion cells responses, until 1 year post injection.

Results : The plasmid constructs containing each optogenes cDNA were able to drive expression of proteins in vitro resulting in an increase of intracellular calcium after light stimulation in HEK293 cells. We demonstrated wide spread transduction of injected retinas with expression of optogenes, as shown by immunostaining of the ChR2 protein on transduced flat mount retina. Nevertheless, we did not detect ERG responses after optogene transfer in a blind canine retina.

Conclusions : Although, the expression cassettes of optogenes have been validated in vitro and the surgical approach led to a large transduction of the retinal ganglion cell, we never detected ERG signal after optogene transfer in Rpe65-/- retinas. Alternative approaches, such as Micro Electrode Array or Visual Evoked Potential experimentations, are still under investigation to evaluate the restoration of visual functions mediated by the optogenes.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×